Log in



The Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) consortium is comprised of a group of children’s hospitals and universities that work closely together to rapidly develop and carry out clinical trials. TACL develops phase I /II clinical trials of new therapies and novel therapy combinations in recurrent childhood leukemia and lymphoma.

Our Mission

To develop innovative therapies for incurable leukemias and lymphomas

"About TACL
"Clinical Trials
"Member Access
"Contact Us
"Make a Donation
"2017 TACL Investigator Meeting
"2019 TACL Investigator Conference